Overweight Clinical Trial
Official title:
The Effectiveness and Safety of High Intensity Interval Training Based on Oxidative Stress and Inflammatory Markers in the Management of Overweight Male Subjects
Verified date | March 2023 |
Source | Indonesia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers. This research used experimental model to test structured high intensity interval training program with pre-post test in single group. Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety. Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness. Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.
Status | Completed |
Enrollment | 16 |
Est. completion date | December 31, 2022 |
Est. primary completion date | October 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 30 Years |
Eligibility | Inclusion Criteria: - overweight (BMI 25 - 29,9) - live in Jakarta and greater area - willing to participate Exclusion Criteria: - smoking - any medical health problems (epilepsy, cardiovascular disease, kidney and liver problems, history of fractures, tendon and ligament injuries) |
Country | Name | City | State |
---|---|---|---|
Indonesia | Fakultas Kedokteran Universitas Indonesia | Jakarta Pusat | DKI Jakarta |
Indonesia | Universitas Indonesia | Jakarta Pusat | DKI Jakarta |
Lead Sponsor | Collaborator |
---|---|
Indonesia University |
Indonesia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | cardiorespiratory fitness | VO2Max in ml/kg/minute | 12 weeks | |
Primary | body mass index | weight and height combined as BMI in kg/m2 | week 4 | |
Primary | body mass index | weight and height combined as BMI in kg/m2 | week 8 | |
Primary | body mass index | weight and height combined as BMI in kg/m2 | week 12 | |
Primary | body fat mass | total fat mass in the body as percentage | week 4 | |
Primary | body fat mass | total fat mass in the body as percentage | week 8 | |
Primary | body fat mass | total fat mass in the body as percentage | week 12 | |
Primary | visceral fat | body fat stored within abdominal cavity as ratings | week 4 | |
Primary | visceral fat | body fat stored within abdominal cavity as ratings | week 8 | |
Primary | visceral fat | body fat stored within abdominal cavity as ratings | week 12 | |
Primary | waist circumference | circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm | week 4 | |
Primary | waist circumference | circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm | week 8 | |
Primary | waist circumference | circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm | week 12 | |
Primary | lipid profile | total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride | 12 weeks | |
Primary | antioxidant level | SOD in U/mg | 12 weeks | |
Primary | free radicals level | MDA in nmol/mg | 12 weeks | |
Primary | inflammation | TNF-alpha in microgram/ml | 12 weeks | |
Primary | interleukin level | IL-6 nanogram/ml | 12 weeks | |
Secondary | Fat Burning Effect | FGF21 | week 1, 6, 12 | |
Secondary | Myokin | Irisin | week 1, 6, 12 | |
Secondary | Cognitive Function Screening | Montreal Cognitive Assessment as score | week 1 and 12 | |
Secondary | Working memory Capacity | N-Back test as percentage of correct answers | week 1 and 12 | |
Secondary | Executive Function | Trail Making Test A and B as seconds | week 1 and 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A | |
Completed |
NCT02829229 -
Community-based Obesity Treatment in African American Women After Childbirth
|
N/A |